Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KATHLEEN EVANS

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI
1790923563
CMS profile
172878
Location
BOAZ, AL

General Payments · PY2018–2024

$3,892.44

  • Reported across 218 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$292.43

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $292.43 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $79.88 2
Amgen Inc. $73.51 4
Janssen Pharmaceuticals, Inc $50.71 3
Merck Sharp & Dohme Corporation $37.59 2
CVRx Inc. $34.17 2
E.R. Squibb & Sons, L.L.C. $16.57 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $974.54 57
PY2019 $1,086.33 61
PY2020 $614.21 35
PY2021 $331.77 19
PY2022 $415.65 23
PY2023 $177.51 9
PY2024 $292.43 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $17.72 01/24/2024 Food and Beverage Undisputed 01/23/2026 1111571732 CMS
Amgen Inc. $18.33 05/09/2024 Food and Beverage Undisputed 01/23/2026 1111571734 CMS
Amgen Inc. $19.57 10/07/2024 Food and Beverage Undisputed 01/23/2026 1111571736 CMS
Amgen Inc. $17.89 11/08/2024 Food and Beverage Undisputed 01/23/2026 1111571738 CMS
CVRx, Inc. $19.53 04/11/2024 Food and Beverage Undisputed 01/23/2026 1128521148 CMS
CVRx, Inc. $14.64 06/14/2024 Food and Beverage Undisputed 01/23/2026 1128521150 CMS
E.R. Squibb & Sons, L.L.C. $16.57 10/29/2024 Food and Beverage Undisputed 01/23/2026 1101252942 CMS
Janssen Pharmaceuticals, Inc $18.25 05/02/2024 Food and Beverage Undisputed 01/23/2026 1077904523 CMS
Janssen Pharmaceuticals, Inc $16.57 05/14/2024 Food and Beverage Undisputed 01/23/2026 1077904513 CMS
Janssen Pharmaceuticals, Inc $15.89 06/12/2024 Food and Beverage Undisputed 01/23/2026 1077904515 CMS
Merck Sharp & Dohme LLC $23.96 05/23/2024 Food and Beverage Undisputed 01/23/2026 1141573283 CMS
Merck Sharp & Dohme LLC $13.63 10/31/2024 Food and Beverage Undisputed 01/23/2026 1141573257 CMS
Novo Nordisk Inc $18.84 09/03/2024 Food and Beverage Undisputed 01/23/2026 1096818269 CMS
Novo Nordisk Inc $61.04 10/23/2024 Food and Beverage Undisputed 01/23/2026 1096912594 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.